Vertex Pharmaceuticals Inc
Close on Nov 19, 2026Market cap $131.97BP/E 30.3Yield –
Vertex Pharmaceuticals Other revenues by Quarter
Other revenues (collaborative & royalty revenues, $M) ($M)
Vertex Pharmaceuticals Other revenues: $0M in Q2 2026, down 100.0% from a year earlier. That is the lowest of the 34 quarters on record here.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Revenue Disaggregation Note.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up other revenues
Cite this data
StockData. (2026). Vertex Pharmaceuticals Other revenues ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-collab-royalty
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?